Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: An overview of Cochrane Reviews

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 1, 2017, Pages

  Els, Charl ^a   Kunyk, Diane ^a   Lappi, Vernon G ^a   Sonnenberg, Barend ^b   Hagtvedt, Reidar ^c   Sharma, Sangita ^a   Kolahdooz, Fariba ^a   Straube, Sebastian ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Emergency Medical Services   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ACUTE DRUG ADMINISTRATION; ADVERSE DRUG REACTION; ADVERSE OUTCOME; ARTICLE; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DEPRESSION; DISEASE SEVERITY; ENDOCRINE DISEASE; HUMAN; HYPOGONADISM; INFECTION; MOOD DISORDER; OPIATE ADDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; SEXUAL DYSFUNCTION; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; XEROSTOMIA;

EID: 85009912376     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012509     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Arlington: American Psychiatric Association, 2013.
2. Bohnert AS, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. American Journal of Psychiatry 2012;169(1):64-70.
3. Borg L, Buonora M, Butelman ER, Ducat E, Ray BM, Kreek MJ. The pharmacology of opioids. In: Ries RK, Fiellin DA, Miller SC, Saitz R editor(s). The ASAM Principles of Addiction Medicine. 5th Edition. Philadelphia: American Society of Addiction Medicine, 2014:135-50.
4. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad, Breivik Hals EK, et al. Assessment of pain. British Journal of Anaesthesia 2008;101(1):17-24.
5. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR. Recommendations and Reports 2016;65(RR-1):1-49. [dx.doi.org/10.15585/mmwr.rr6501e1]
6. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. Journal of Pain 2010;11(9):807-29.
7. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310(6977):452-4.
8. Els C, Hagtvedt R, Kunyk D, Sonnenberg B, Lappi VG, Straube S. High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD012299]
9. Franklin GM. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014;83(14):1277-84. [DOI: 10.1212/WNL.0000000000000839]
10. Gomes T, Mamdani MM, Paterson JM, Dhalla IA, Juurlink DN. Trends in high-dose opioid prescribing in Canada. Canadian Family Physician 2014;60(9):826-32.
11. Hegmann KT, Weiss MS, Bowden K, Branco F, DuBrueler K, Els C, et al. ACOEM practice guidelines: opioids and safety-sensitive work. Journal of Occupational and Environmental Medicine 2014;56(7):e46-53. [DOI: 10.1097/JOM.0000000000000237]
12. Hegmann KT, Weiss MS, Bowden K, Branco F, DuBrueler K, Els C, et al. ACOEM practice guidelines opioids for treatment of acute, subacute, chronic, and postoperative pain. Journal of Occupational and Environmental Medicine 2014;56(12):e143-59. [DOI: 10.1097/JOM.0000000000000352]
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. The Cochrane Collaboration, Available from handbook.cochrane.org.
14. Huffman KL, Shella ER, Sweis G, Griffith SD, Scheman J, Covington EC. Nonopioid substance use disorders and opioid dose predict therapeutic opioid addiction. Journal of Pain 2015;16(2):126-34. [DOI: 10.1016/j.jpain.2014.10.011]
15. Häuser W, Bock F, Engeser P, Tölle T, Willweber-Strumpf A, Petzke F. Clinical practice guideline: long-term opioid use in non-cancer pain. Deutsches Ärzteblatt International 2014;111:732-40. [DOI: 10.3238/arztebl.2014.0732]
16. Jungquist CR, Flannery M, Perlis ML, Grace JT. Relationship of chronic pain and opioid use with respiratory disturbance during sleep. Pain Management Nursing 2012;13(2):70-9. [DOI: 10.1016/j.pmn.2010.04.003]
17. Katz JA, Swerdloff MA, Brass SD, Argoff CE, Markman J, Backonja M, et al. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2015;84(14):1503-4. [DOI: 10.1212/WNL.0000000000001485]
18. Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. Journal of Bone and Joint Surgery 2009;91(4):919-27.
19. Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Science & Practice Perspectives 2002;1(1):13-20.
20. Kraut A, Shafer LA, Raymond CB. Proportion of opioid use due to compensated workers' compensation claims in Manitoba, Canada. American Journal of Industrial Medicine 2015;58(1):33-9. [DOI: 10.1002/ajim.22374]
21. Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9-38.
22. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 - guidance. Pain Physician 2012;15(3 Suppl):S67-116.
23. McQuay HJ, Derry S, Eccleston C, Wiffen PJ, Moore RA. Evidence for analgesic effect in acute pain - 50 years on. Pain 2012;153(7):1364-7. [DOI: 10.1016/j.pain.2012.01.024]
24. Merskey H, Lindblom U, Mumford JM, Nathan PW, Sunderland S. Part III: pain terms, a current list with definitions and notes on usage. In: Merskey H, Bogduk N editor(s). Classification of Chronic Pain. 2nd Edition. Seattle: IASP Press, IASP Task Force on Taxonomy, 1994:209-14.
25. Moore AR, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79-94. [DOI: 10.1111/papr.12050]
26. Moore RA, Derry S, Aldington D, Wiffen PJ. Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD011407.pub2]
27. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. nationalpaincentre.mcmaster.ca/opioid/documents.html (accessed 8 July 2016).
28. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Annals of Internal Medicine 2014;160(1):38-47. [DOI: 10.7326/0003-4819-160-1-201401070-00732]
29. Portenoy R, Foley K. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25(2):171-86.
30. Rachinger-Adam B, Conzen P, Azad SC. Pharmacology of peripheral opioid receptors. Current Opinion in Anaesthesiology 2011;24(4):408-13.
31. Rass O, Schacht RL, Marvel CL, Mintzer MZ. Opioids. In: Allen DN, Woods SP editor(s). Neuropsychological Aspects of Substance Use Disorders: Evidence-Based Perspectives. New York: Oxford University Press, 2014:231-53.
32. Schulteis G, Koob GF. Reinforcement processes in opiate addiction: a homeostatic model. Neurochemical Research 1996;21(11):1437-54.
33. Shafer LA, Raymond C, Ekuma O, Kraut A. The impact of opioid prescription dose and duration during a workers compensation claim, on post-claim continued opioid use: a retrospective population-based study. American Journal of Industrial Medicine 2015;58(6):650-7. [DOI: 10.1002/ajim.22453]
34. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:1-10. [DOI: 10.1186/1471-2288-7-10]
35. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156(4):569-76. [DOI: 10.1097/01.j.pain.0000460357.01998.f1]
36. Vuong C, Van Uum SHM, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Reviews 2010;31(1):98-132. [DOI: 10.1210/er.2009-0009]
37. Walker JM, Farney RJ, Rhondeau SM, Boyle KM, Valentine K, Cloward TV, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. Journal of Clinical Sleep Medicine 2007;3(5):455-61.
38. World Health Organization. Cancer pain relief: with a guide to opioid availability. 2nd Edition. Geneva: WHO, 1996.
39. Windmill J, Fisher E, Eccleston C, Derry S, Stannard C, Knaggs R, et al. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD010323.pub2]
40. Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. European Journal of Pain 2014;18(9):1343-51. [DOI: 10.1002/j.1532-2149.2014.496.x]
41. Zutler M, Holty JE. Opioids, sleep, and sleep-disordered breathing. Current Pharmaceutical Design 2011;17(15):1443-9.